Is ILMN a good stock to buy?
Illumina, Inc. · end-of-day data as of Nov 13, 2026
- PT$230.14 +11.2%
- Trendbullish
- Sector▲ +15.9%
- Earnings in83d
- P/E35.6x
- RSI35
- Support-1.1%
- Resistance+27.3%
- Off 52w high-33.1%
- Volume0.6x
- Bollingerlower half
- News1.00
- FCF yield+3.4%
- ConsensusHold · 22
- 52w range$113–$309
- ATR+7.3%
- Off ATH-61.7%
- P/E vs own+13.5%
- P/E vs sector+10.4%
- Insiders-$416M
- MAs1 of 4
- MA20×50Death 1d ago
- MACD-5.19
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Illumina a good stock to buy?
Illumina is strong on 2 of the 3 questions about the business; weak on demand. Illumina's P/E ratio is 35.6 (Nov 13, 2026). pretickt does not say whether to buy or sell.
ILMN sales growth revenue growth
-2%a year, for the last 3 yearsIllumina's sales fell 2% a year for 3 years, to $4.34B in fiscal 2025.
ILMN analysts' forecast revenue estimates
+7%the sales they expect next fiscal year, on the lastAnalysts expect Illumina's sales to grow 7% to $4.63B in fiscal 2026 (14 analysts).
ILMN competitors
pretickt analysis+6%its sales in 12 months, on a year before
Illumina's sales grew 6% in the 12 months to Sep 27, 2026, slower than Quest Diagnostics (+9%), IQVIA (+9%), Mettler-Toledo (+7%) and Labcorp (+6%).
ILMN sales by business revenue by segment
92%of its sales from SequencingSequencing brought Illumina 92% of its sales in fiscal 2025; Microarray 8%.
ILMN earnings vs estimates
7 of 8quarters above the analysts' estimateIllumina beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 29, 2026.
ILMN insider selling
-$721Msold, net, by its executives in 12 monthsIllumina's executives and directors sold a net $721M of shares in the 12 months to Nov 13, 2026 ($721M sold, $23.56K bought).
ILMN number of employees
-4%fewer people in a yearIllumina had 8,600 employees at the end of fiscal 2025, 4% fewer than a year before.
ILMN CEO pay
$11.02Mfor fiscal 2025, 80% of it in stock and optionsIllumina paid its CEO $11.02M for fiscal 2025, 80% of it in stock and options.
ILMN financial health Altman Z-score
6.8Altman Z-score, safe above 3Illumina's Altman Z-score is 6.8 (Nov 13, 2026), above 3, where the safe zone starts.
ILMN quality checks Piotroski score
7 of 9checks passedIllumina passes 7 of the 9 Piotroski checks in the 12 months to Sep 27, 2026; it misses on long-term debt and sales for its assets.
ILMN biggest customers
under 10%of sales from any one customerNo customer made 10% of Illumina's sales in fiscal 2025.
ILMN in past recessions
pretickt analysis-9%its sales in the worst oneIllumina's sales fell in 1 of the last 2 US recessions, by as much as 9% in fiscal 2020.
ILMN price vs profit P/E ratio
35.6×a year's earningsIllumina's P/E ratio is 35.6 (Nov 13, 2026).
ILMN price vs competitors
pretickt analysis35.6×a year's earnings, against its competitorsInvestors pay 35.6 times Illumina's earnings (Nov 13, 2026), more than for IQVIA (32.2), Labcorp (30.4) and Quest Diagnostics (25.9), less than for Mettler-Toledo (37.7).
ILMN analysts' target price target
+11%to their average targetAnalysts' average price target for Illumina is $230, 11% above the Nov 13, 2026 close of $207.01.
ILMN analyst ratings, 90 days
pretickt analysisUBSupgrade
In the 90 days to Nov 13, 2026, UBS upgraded Illumina.
What is Illumina's P/E ratio?
Illumina's P/E ratio is 35.6 (Nov 13, 2026). Investors pay 35.6 times Illumina's earnings (Nov 13, 2026), more than for IQVIA (32.2), Labcorp (30.4) and Quest Diagnostics (25.9), less than for Mettler-Toledo (37.7).
Who are Illumina's biggest competitors?
pretickt compares Illumina with Labcorp, Quest Diagnostics, Mettler-Toledo and IQVIA. Illumina's sales grew 6% in the 12 months to Sep 27, 2026, slower than Quest Diagnostics (+9%), IQVIA (+9%), Mettler-Toledo (+7%) and Labcorp (+6%).
Who is dumping Illumina stock?
Illumina's executives and directors sold a net $721M of shares in the 12 months to Nov 13, 2026 ($721M sold, $23.56K bought).
How does Illumina make money?
Sequencing brought Illumina 92% of its sales in fiscal 2025; Microarray 8%.
How many employees does Illumina have?
Illumina had 8,600 employees at the end of fiscal 2025, 4% fewer than a year before.
Who are Illumina's biggest customers?
No customer made 10% of Illumina's sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.